BOB体育

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550 (study鈥�

Investigator

Christopher Harden

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Investigator

Christopher Harden

Status

Accepting Candidates

Ages

21 Years - N/A

Sexes

All

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Investigator

Christopher Harden

Status

Accepting Candidates

Ages

21 Years - N/A

Sexes

All